Literature DB >> 27692521

[Does hyperandrogenic statute in the polycystic ovary syndrome constitute an obstacle to the success of in vitro fertilization?]

M Gaddas1, N Chaouache2, M Ajina3, Z Tabka2, M Zaouali Ajina2.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the impact of initial androgenic statute of women with polycystic ovary syndrome (SOPK) on the expected results of in vitro fertilization (FIV).
MATERIALS AND METHODS: It is about an exploratory study carried out in 61 unfertile SOPK patients, having profited all from a cycle of FIV/ICSI (intracytoplasmic sperm injection). We have divided our population in two groups according to their hormonal androgenic statute: groups with hyperandrogenism and without hyperandrogenism. We proceeded to note the anthropometric and hormonal parameters as well as results of FIV for each of the two groups.
RESULTS: SOPK patients with hyperandrogenism are more obese than their counterparts. Also, they have more oocytes collected after ovarian induction. In addition, we did not reveal any significant differences between our two study groups concerning parameters defining FIV response.
CONCLUSION: Our findings suggest that hyperandrogenism statute in SOPK infertile women does not seem to compromise the results of FIV. On the contrary, it would make it possible to optimize the chances to puncture more significant number of oocytes.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  FIV; Hyperandrogenism; Hyperandrogénie; IVF; Polycystic ovarian syndrome; Syndrome des ovaires polykystiques

Mesh:

Year:  2016        PMID: 27692521     DOI: 10.1016/j.jgyn.2016.08.007

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  2 in total

1.  Polycystic ovary syndrome phenotype does not have impact on oocyte morphology.

Authors:  Audrey Uk; Christine Decanter; Camille Grysole; Laura Keller; Hélène Béhal; Mauro Silva; Didier Dewailly; Geoffroy Robin; Anne-Laure Barbotin
Journal:  Reprod Biol Endocrinol       Date:  2022-01-05       Impact factor: 5.211

2.  Body mass index and basal androstenedione are independent risk factors for miscarriage in polycystic ovary syndrome.

Authors:  Wan Yang; Rui Yang; Mingmei Lin; Yan Yang; Xueling Song; Jiajia Zhang; Shuo Yang; Ying Song; Jia Li; Tianshu Pang; Feng Deng; Hua Zhang; Ying Wang; Rong Li; Jie Jiao
Journal:  Reprod Biol Endocrinol       Date:  2018-11-19       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.